clinicalaccelerator.com

What It Is

Clinical Accelerator is a Sponsor-Aligned CRO focused on early clinical development for innovative medical devices, rather than a typical SaaS product. Its core focus is on First-in-Human (FIH) and Early Human Feasibility studies across Eastern Europe and Central Asia. It positions itself as helping MedTech companies generate clinical evidence through faster study startup, more efficient recruitment, and more controllable budgets.

Core Capabilities

Based on the website information, its core modules include feasibility assessment, country and site selection, regulatory liaison, site startup, contracts and logistics, patient screening and recruitment, study monitoring, data quality, and compliance documentation management. The company emphasizes its SMPEO model, trusted site network, flat project structure, and collaboration with academic advisors and KOLs. It highlights experience in innovative device projects, particularly in complex cardiovascular disease, structural heart disease, heart failure, and interventional oncology.

Pricing and Business Model

The website does not provide standard packages, price lists, or payment methods. Instead, it directs potential clients to schedule a feasibility call to assess feasibility, sites, and timelines. This suggests a project-based, custom-quote model. For early-stage medical device companies, this approach makes it easier to design budgets around indication, country, number of sites, and regulatory complexity, though upfront pricing transparency is limited.

Pros and Cons

Its strength lies in its highly focused positioning: specializing in FIH and early feasibility studies for medical devices, while emphasizing startup speed, recruitment capability, and cost efficiency in Eastern Europe and Central Asia. The abundance of client testimonials suggests hands-on experience in regulatory affairs, customs, site relationships, monitoring, and recruitment. The limitations are that the website does not disclose quality system certifications, data security standards, detailed SOPs, service boundaries, or standard pricing. It also does not showcase a software platform, API, self-service admin dashboard, or developer capabilities.

Who It’s For

Clinical Accelerator is suitable for MedTech or early-stage biotech companies from the United States, Europe, Israel, Australia, and Asia, especially teams that need to find high-quality clinical sites outside saturated Western markets, complete FIH/feasibility studies quickly, and control cash burn. It is less suitable for users looking for standardized clinical trial SaaS, eTMF/EDC software, or China-based clinical trial execution capabilities.

Access in China

The main content does not mention access from mainland China, Chinese-language services, or local Chinese client cases. Its access status is therefore rated as unknown.